Neurogene to Participate in Upcoming Investor Conferences
Format: Management will participate in a
Date:
Format: Management will participate in investor meetings
Date:
Stifel 2024 Virtual CNS Days
Format: Management will participate in a fireside chat
Date:
Live webcasts of the panel and fireside chat can be accessed from the Investor Relations section of Neurogene’s website under events, where a replay of the events will also be available for a limited time.
About Neurogene
The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders. This includes selecting a delivery approach to maximize distribution to target tissues and by designing products to maximize potency and purity for an optimized efficacy and safety profile. The Company’s novel and proprietary EXACT transgene regulation platform technology allows for the delivery of therapeutic levels while limiting transgene toxicity associated with conventional gene therapy. Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240229815231/en/
Neurogene Contacts:
Investor Relations:
Neurogene@argotpartners.com
Media:
david.rosen@argotpartners.com
Source: